Quant-Equipoise 500 HP

Quant-Equipoise 500 HP

  • Brand: Beligas - US
  • Product Code: Quant-Equipoise 500 HP
  • Availability: In Stock
  • $98.00



ACTIVE HALF-LIFE 14 days
CLASSIFICATION Anabolic Steroid
DOSAGE Men: 400-1000 mg/week
ACNE Rarely experienced
WATER RETENTION Minimal
HBR Not present
HEPATOTOXICITY Low risk
AROMATIZATION Low tendency
MANUFACTURER Beligas - US
LAB TEST Refer to Document
WAREHOUSE Located in USA Warehouse 2
SUBSTANCE Boldenone Undecylenate

Introducing Quant-Equipoise, featuring Boldenone Undecylenate as its key ingredient. This powerful anabolic steroid is designed to elevate your performance and physique.

Benefits of Quant-Equipoise

  • Facilitates impressive muscle growth
  • Offers a mild flavor profile
  • Stimulates appetite for optimal gains
  • Enhances vascularity for a defined look
  • Increases strength levels significantly
  • Improves oxygen transport efficiency
  • Exhibits low androgenic activity, minimizing unwanted side effects
  • Minimal side effects, such as acne and slight elevation in blood pressure
  • May cause a slight decrease in natural testosterone production
  • Low hepatotoxicity, making it a safer choice

Possible Side Effects

While Quant-Equipoise is well-tolerated, potential side effects may include acne, elevated blood pressure, and prostate enlargement. These issues can typically be managed with effective monitoring and post-cycle therapy.

Recommended Quant-Equipoise Cycles

  • For beginners: 8-week cycle at 800mg per week of Boldenone Undecylenate, paired with 40mg of Turanabol daily.
  • For experienced users:
  • 8-week cycle at 600mg per week of Boldenone Undecylenate, combined with 100mg Propionate every other day and 40mg of Winstrol daily.
  • For advanced users:
  • 8-week cycle at 800mg per week of Boldenone Undecylenate, along with 300-400mg of Trenbolone 100 weekly.

Important Notice: Keep out of reach of children. For adult use only.

Caution: Always consult with a healthcare professional before beginning any new supplement regimen.